Aspergillus Infections in Transplant Recipients

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Microbiology Reviews

• Publication date

  2005-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/CMR.18.1.44-69.2005PMID 15653818PMCID PMC544171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection ofAspergillus DNA in bronchoalveolar lavage fluid of AIDS patients by the polymerase chain reaction

  2005influential reference
• Combined Activity In Vitro of Caspofungin, Amphotericin B, and Azole Agents against Itraconazole-Resistant Clinical Isolates of Aspergillus fumigatus

  2005cited by this paper
• Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia

  2005cited by this paper
• Combination Antifungal Therapy for Invasive Aspergillosis

  2005cited by this paper
• Infectious complications in 100 consecutive heart transplant recipients

  2005cited by this paper
• Stem cell plasticity: time for a reappraisal?

  2005cited by this paper
• Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies.

  2004influential reference
• Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient

  2004cited by this paper
• Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

  2004cited by this paper
• False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.

  2004cited by this paper
• Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.

  2004cited by this paper
• Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection.

  2004cited by this paper
• Efficacy of Galactomannan Antigen in the Platelia Aspergillus Enzyme Immunoassay for Diagnosis of Invasive Aspergillosis in Liver Transplant Recipients

  2004cited by this paper
• Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.

  2004influential reference
• Vaccinate against aspergillosis! A call to arms of the immune system.

  2004cited by this paper
• Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.

  2004cited by this paper
• Prospective Comparison of the Diagnostic Potential of Real-Time PCR, Double-Sandwich Enzyme-Linked Immunosorbent Assay for Galactomannan, and a (1→3)-β-d-Glucan Test in Weekly Screening for Invasive Aspergillosis in Patients with Hematological Disorders

  2004cited by this paper
• Prospective Assessment of Platelia™Aspergillus Galactomannan Antigen for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients

  2004cited by this paper
• Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.

  2004cited by this paper
• Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.

  2004cited by this paper
• Combination antifungal therapy for invasive aspergillosis.

  2004cited by this paper
• Pharmacokinetics of Posaconazole Coadministered with Antacid in Fasting or Nonfasting Healthy Men

  2004cited by this paper
• Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients.

  2004cited by this paper
• Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.

  2004cited by this paper
• Risk Factors of Invasive Aspergillosis after Heart Transplantation: Protective Role of Oral Itraconazole Prophylaxis

  2004cited by this paper
• Cyclophosphamide metabolism is affected by azole antifungals.

  2004cited by this paper
• Reactivity of Platelia Aspergillus Galactomannan Antigen with Piperacillin-Tazobactam: Clinical Implications Based on Achievable Concentrations in Serum

  2004cited by this paper
• Management of Aspergillus Osteomyelitis: Report of Failure of Liposomal Amphotericin B and Response to Voriconazole in an Immunocompetent Host and Literature Review

  2003cited by this paper
• New Methods To Assess Susceptibilities of Aspergillus Isolates to Caspofungin

  2003cited by this paper
• Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study1

  2003cited by this paper
• Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.

  2003cited by this paper
• The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human.

  2003cited by this paper
• Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy

  2003cited by this paper
• Echinocandin antifungal drugs.

  2003influential reference
• Benefit of surgical resection of invasive pulmonary aspergillosis in pediatric patients undergoing treatment for malignancies and immunodeficiency syndromes.

  2003cited by this paper
• The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis1

  2003cited by this paper
• Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin.

  2003cited by this paper
• Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy

  2003cited by this paper
• Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients.

  2003influential reference
• Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity.

  2003cited by this paper
• Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management.

  2003influential reference
• In Vitro Synergy of Caspofungin and Itraconazole against Aspergillus spp.: MIC versus Minimal Effective Concentration End Points

  2003cited by this paper
• Refractory Aspergillus pneumonia in patients with acute leukemia

  2003cited by this paper
• Caspofungin in combination with itraconazole and amphotericin B for the treatment of invasive Aspergillosis in humans, with a method to test ex vivo synergism.

  2003cited by this paper
• Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin.

  2003cited by this paper
• Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus.

  2003cited by this paper
• Treatment of opportunistic mycoses: how long is long enough?

  2003cited by this paper
• Shedding light on microbial detection.

  2003cited by this paper
• Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients.

  2003cited by this paper
• Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

  2003cited by this paper
• Nebulized amphotericin B concentration and distribution in the respiratory tract of lungtransplanted patients

  2003cited by this paper
• Outbreak of invasive aspergillosis among renal transplant recipients.

  2003cited by this paper
• Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction.

  2003influential reference
• Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.

  2003cited by this paper
• Aspergillus endophthalmitis: an unusual complication of disseminated infection in renal transplant patients.

  2003cited by this paper
• Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial

  2003cited by this paper
• False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

  2003cited by this paper
• In Vitro Activities of Voriconazole, Posaconazole, and Four Licensed Systemic Antifungal Agents against Candida Species Infrequently Isolated from Blood

  2003cited by this paper
• Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.

  2003cited by this paper
• Comparison of Etest with Modified Broth Microdilution Method for Testing Susceptibility of Aspergillus spp. to Voriconazole

  2003cited by this paper
• Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults

  2003cited by this paper
• Two Cases of Cerebral Aspergillosis Successfully Treated with Voriconazole

  2003cited by this paper
• A B Cell-Based Sensor for Rapid Identification of Pathogens

  2003cited by this paper
• Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.

  2003influential reference
• Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species.

  2003cited by this paper
• Successful treatment with voriconazole of cerebral aspergillosis in an hematologic patient.

  2003cited by this paper
• Co-administration of Caspofungin and Cyclosporine to a Kidney Transplant Patient with Pulmonary Aspergillus Infection

  2003cited by this paper
• Invasive aspergillosis in the setting of cardiac transplantation.

  2003cited by this paper
• Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning.

  2003cited by this paper
• Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.

  2003cited by this paper
• Glucocorticoids and invasive fungal infections.

  2003cited by this paper
• Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis.

  2003cited by this paper
• Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent.

  2002cited by this paper
• From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 22, 2013. For personal use only.

  2002influential reference
• Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies.

  2002cited by this paper
• Polymerase chain reaction detection of aspergillus DNA in experimental models of invasive aspergillosis.

  2002cited by this paper
• Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

  2002cited by this paper
• Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

  2002cited by this paper
• A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients.

  2002cited by this paper
• In Vitro Interaction of Caspofungin Acetate with Voriconazole against Clinical Isolates of Aspergillus spp

  2002cited by this paper
• Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin.

  2002cited by this paper
• In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.

  2002cited by this paper
• Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?

  2002cited by this paper
• Safety and tolerability of caspofungin acetate in the treatment of fungal infections

  2002cited by this paper
• In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp

  2002cited by this paper
• Delayed Occurrence of Cytomegalovirus Disease in Organ Transplant Recipients Receiving Antiviral Prophylaxis: Are We Winning the Battle Only to Lose the War?

  2002cited by this paper
• Real-Time PCR Coupled with Automated DNA Extraction and Detection of Galactomannan Antigen in Serum by Enzyme-Linked Immunosorbent Assay for Diagnosis of Invasive Aspergillosis

  2002cited by this paper
• Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.

  2002cited by this paper
• Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices.

  2002cited by this paper
• Massive intracerebral aspergillosis responding to combination high dose liposomal amphotericin B and cytokine therapy without surgery.

  2002cited by this paper
• Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis.

  2002cited by this paper
• Follow‐up of anti‐Aspergillus IgG and IgA antibodies in bone marrow transplanted patients with invasive aspergillosis

  2002cited by this paper
• Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study.

  2002cited by this paper
• Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.

  2002influential reference
• Systemic Fungal Infections after Renal Transplantation

  2002cited by this paper
• Successful Treatment of Paecilomyces lilacinus Endophthalmitis with Voriconazole

  2002cited by this paper
• Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

  2002cited by this paper
• Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture?

  2002cited by this paper
• Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

  2002cited by this paper
• Full thoracoscopic approach for surgical management of invasive pulmonary aspergillosis.

  2002cited by this paper

• Invasive aspergillosis in lung and heart transplant recipients.

  2026cites this paper
• Follow-up of Surgical and Nonsurgical Patients With Pulmonary Aspergillosis: A Real-World Study

  2025cites this paper
• Aspergillosis on YouTube: Assessment of Quality and Reliability of Uploaded Videos

  2025cites this paper
• Airborne Fungal Communities: Diversity, Health Impacts, and Potential AI Applications in Aeromycology

  2025cites this paper
• Exploring Emerging Antifungal Drugs Regime for Aspergillus-Associated Infections

  2025cites this paper
• Outcome of Liver Transplantation for Critically Ill Acute on Chronic Liver Failure Recipients Complicated With Pretransplant Invasive Pulmonary Aspergillosis.

  2025cites this paper
• Utility of serum galactomannan in diagnosing invasive aspergillosis among hematology patients: a meta-analysis

  2025cites this paper
• Increasing the Sensitivity of Aspergillus Galactomannan ELISA Using Silver Nanoparticle-Based Surface-Enhanced Raman Spectroscopy

  2025cites this paper
• Plasma Cell-free DNA Associated With Risk of Mortality and Chronic Lung Allograft Dysfunction Among Lung Transplant Recipients With Aspergillus

  2025cites this paper
• Real-time and digital PCR assays for the detection of Aspergillus DNA in contrived and clinical samples—a bi-center evaluation

  2025cites this paper
• Understanding Fungi-Host Dynamics: The Role of Immuno Suppression and Real-World Clinical Scenario

  2025cites this paper
• Vaccination with O-linked Mannans Protects against Systemic Candidiasis through Innate Lymphocyte Populations.

  2024cites this paper
• A review of pathogenic airborne fungi and bacteria: unveiling occurrence, sources, and profound human health implication

  2024cites this paper
• Rapidly progressing necrotizing fasciitis with chickenpox infection: A case series

  2024cites this paper
• The Molecular Basis of the Intrinsic and Acquired Resistance to Azole Antifungals in Aspergillus fumigatus

  2024cites this paper
• Infections in Heart and Lung Transplant Recipients.

  2024cites this paper
• The effect of infectious diseases on lung transplantation in Japan

  2024influential citation
• Fungal Infections and Colonization after Bilateral Lung Transplant: A Six-Year Single-Center Experience

  2024cites this paper
• Renal Aspergillosis Complicating Renal Allograft Transplantation: A Case Report

  2024cites this paper
• Epidemiology and Management of Infections in Liver Transplant Recipients

  2024cites this paper
• S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)

  2024cites this paper
• Identifying genetic susceptibility to Aspergillus fumigatus infection using collaborative cross mice and RNA‐Seq approach

  2024cites this paper
• Time-resolved fluoroimmunoassay for Aspergillus detection based on anti-galactomannan monoclonal antibody from stable cell line.

  2024cites this paper
• Identification of Compounds Preventing A. fumigatus Biofilm Formation by Inhibition of the Galactosaminogalactan Deacetylase Agd3

  2023cites this paper
• FDA Public Workshop Summary-Addressing Challenges in Inhaled Antifungal Drug Development.

  2023cites this paper
• Aspergillus Galactomannan Titer as a Diagnostic Marker of Invasive Pulmonary Aspergillosis in Lung Transplant Recipients: A Single-Center Retrospective Cohort Study

  2023cites this paper
• Infections after organ transplantation and immune response.

  2023cites this paper
• Investigation through the antimicrobial activity of electrospun PCL nanofiber mats with green synthesized Ag–Fe nanoparticles

  2023cites this paper
• Utilization of Raman spectroscopy for identification and characterization of fungal pathogens

  2023cites this paper
• Effect of Mycetoma in Lung Transplant Patients - a Single Center Experience.

  2023cites this paper
• Early-Onset Invasive Pulmonary Aspergillosis in a Liver Transplant Patient: A Case Report

  2023cites this paper
• Immunosuppressive Therapy in Solid Organ Transplantation: Primer for Radiologists and Potential Complications.

  2023cites this paper
• The Virtuous Galleria mellonella Model for Scientific Experimentation

  2023cites this paper
• Invasive aspergillosis in liver transplant recipients

  2023cites this paper
• Modulatory immune responses in fungal infection associated with organ transplant - advancements, management, and challenges

  2023cites this paper
• Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-fumigatus Aspergillus spp.

  2023cites this paper
• CD56-mediated activation of human natural killer cells is triggered by Aspergillus fumigatus galactosaminogalactan

  2023influential citation
• Clinical features and outcomes of small airway disease in ANCA‐associated vasculitis

  2023cites this paper
• Section 1. Colombian consensus on the diagnosis and follow-up of invasive aspergillosis and Aspergillus disease in adult and pediatric patients

  2022cites this paper
• Section 3. Colombian consensus on the diagnosis and treatment of extrapulmonary aspergillosis in adult patients

  2022cites this paper
• Antifungal Prophylaxis and Treatment Among Lung Transplant Recipients in Early Postoperative Stage: A Single-Center Study.

  2022cites this paper
• Isolation and Identification of Aspergillus Spp. from patients with pneumonia in Babylon

  2022cites this paper
• Manifestations, prevalence, management and outcome of Invasive Aspergillosis in Post-Liver Transplant Patients.

  2022cites this paper
• Non-Aspergillus mould lung infections

  2022cites this paper
• Sino-Orbital Aspergillosis in a Kidney Transplant Recipient

  2022cites this paper
• Non- Aspergillus mould lung infections

  2022cites this paper
• Targeted caspofungin prophylaxis for invasive aspergillosis in high‐risk liver transplant recipients, a single‐center experience

  2021cites this paper
• Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation

  2021cites this paper
• Fungal Infections of the Central Nervous System

  2021cites this paper
• Nebulized Amphotericin B Dosing Regimen for Aspergillus Prevention After Lung Transplant.

  2021cites this paper
• A Human Dectin-2 Deficiency Associated With Invasive Aspergillosis

  2021cites this paper
• Fungal pneumonia in kidney transplant recipients.

  2021cites this paper
• Fungal infections in lung transplantation

  2021cites this paper
• Neumonía por Aspergillus lentulus en una paciente con diagnóstico de neumonía organizada criptogénica en tratamiento con corticoides orales

  2021cites this paper
• Clinical and Epidemiological Profile of Patients with Invasive Aspergillosis from a Fourth Level Hospital in Bogota, Colombia: A Retrospective Study

  2021cites this paper
• Spectrum of pulmonary aspergillus diseases in post TB lung diseases.

  2021cites this paper
• Cytokine and Chemokine Responses in Invasive Aspergillosis Following Hematopoietic Stem Cell Transplantation: Past Evidence for Future Therapy of Aspergillosis

  2021cites this paper
• Cytokine Assays

  2021cites this paper
• Aspergillosis: Epidemiology, Diagnosis, and Treatment.

  2021cites this paper
• Isolation and Identification of Aspergillus spp. from Human and Sheep Respiratory Infection in Al-Qadisiyah Province

  2021cites this paper
• Aspergillus in Solid Organ and Stem Cell Transplant Patients: Emerging Options for Diagnosis and Management

  2021cites this paper
• Diagnosis of Pneumonia Due to Invasive Molds

  2021influential citation
• Micro/nanotechnology-inspired rapid diagnosis of respiratory infectious diseases

  2021cites this paper
• Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021

  2021cites this paper
• Risk of Lung Allograft Dysfunction Associated With Aspergillus Infection

  2021cites this paper
• Invasive pulmonary aspergillosis after heart transplantation

  2021influential citation
• The Nationwide Austrian Registry: a prospective data collection on epidemiology; therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients

  2020cites this paper
• Late outcome after surgical and topical treatment for Aspergillus mediastinitis after heart transplantation

  2020influential citation
• Detection of some virulence genes in Aspergillus fumigates isolated from the nasal cavity of cattle in Al-Qadisiyah Province

  2020cites this paper
• Update on Respiratory Fungal Infections in Cystic Fibrosis Lung Disease and after Lung Transplantation

  2020cites this paper
• Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation

  2020cites this paper
• Free circulating mircoRNAs support the diagnosis of invasive aspergillosis in patients with hematologic malignancies and neutropenia

  2020cites this paper
• A case series of non-valvular cardiac aspergillosis in critically ill solid organ transplant and non-transplant patients and systematic review

  2020cites this paper
• Orbital Apex Syndrome Secondary to Invasive Aspergillus Infection: A Case Series and Literature Review

  2020cites this paper
• Synthesis and Structural Analysis of Aspergillus fumigatus Galactosaminogalactans featuring α-galactose, α-galactosamine and α-N-acetyl galactosamine linkages.

  2020cites this paper
• Diagnostic biomarkers for invasive aspergillosis utilizing weighted gene co-expression network analysis

  2020cites this paper
• Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design.

  2020cites this paper
• Successful treatment of Aspergillus fumigatus sternal osteomyelitis with isavuconazole in a heart transplant recipient

  2020cites this paper
• Introduction and Aims

  2020cites this paper
• A Rare Case of Sino-Orbital Invasive Aspergillosis in a Kidney Transplant Recipient

  2020cites this paper
• All that glitters is not gold: a case report of a diffuse peritoneal aspergillosis.

  2020cites this paper
• Exopolysaccharides and Biofilms.

  2020cites this paper
• Infection prophylaxis and management of fungal infections in lung transplant

  2020cites this paper
• Optimization of the antifungal metabolite production in Streptomyces libani isolated from northern forests soils in Iran

  2020cites this paper
• Isavuconazole is as effective as and better tolerated than voriconazole for antifungal prophylaxis in lung transplant recipients.

  2020cites this paper
• Liver Transplantation in Patients with Pretransplant Aspergillus Colonization: Is It Safe To Proceed?

  2020cites this paper
• A Rare Presentation of the Most Rare Entity

  2019cites this paper
• Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline

  2019cites this paper
• ASP2397 Is a Novel Natural Compound That Exhibits Rapid and Potent Fungicidal Activity against Aspergillus Species through a Specific Transporter

  2019cites this paper
• National trends in incidence, prevalence and disability-adjusted life years of invasive aspergillosis in Iran: a systematic review and meta-analysis

  2019cites this paper
• Invasive Aspergillosis in solid‐organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

  2019cites this paper
• Тромбоциты при инвазивном аспергиллезе: роль в патогенезе и иммунной защите

  2019cites this paper
• Epidemiology of fungal infections: What, where, and when

  2019cites this paper
• Characterization of crystal structure and key residues of Aspergillus fumigatus nucleoside diphosphate kinase.

  2019cites this paper
• Hepatobiliary Tract Infections

  2019cites this paper
• Invasive Fungal Disease in the Transplant Population: An Overview

  2019cites this paper
• Platelets in invasive aspergillosis: role in pathogenesis and immune defense

  2019cites this paper
• Immunotherapy for Invasive Mold Disease in Transplant Patients: Dendritic Cell Immunotherapy, Interferon Gamma, Recombinant Myeloid Growth Factors, and Healthy Donor Granulocyte Transfusions

  2019cites this paper
• Enhanced labile plasma iron in hematopoietic stem cell transplanted patients promotes Aspergillus outgrowth.

  2019cites this paper
• Atypical Presentation of Aspergillus Mediastinitis Infection in a Heart Transplant Patient: the Importance of Combined Medical and Surgical Treatment.

  2019cites this paper